Meta-analysis · people

Setmelanotide: injection-site reactions in 96% in pooled trials

Checked against the paper Meta-analysisPublished by PepVault

The takeaway

Injection-site reactions and skin darkening were the most common side effects seen with setmelanotide, followed by stomach effects such as nausea, vomiting and diarrhea.

Kind
Meta-analysis
Studied in
People
Number studied
185
Published
2026
Journal
Expert Opin Drug Saf

What they tested

The team set out to map the side effects linked to setmelanotide in obesity, using several sources of safety data together.

How the study was done

A systematic review and meta-analysis that pooled clinical trials with 185 people in total. The team also checked 228 reports in the US FDA Adverse Event Reporting System, a database of side-effect reports, and reviewed published case reports.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In the pooled trials, 96% of people had injection-site reactions (95% CI, the likely range: 89 to 100) and 62% had skin hyperpigmentation (95% CI: 43 to 78). Nausea occurred in 36%, vomiting in 26% and diarrhea in 21%. In the FDA database, the side effects reported more often than expected were skin hyperpigmentation, injection-site reactions, nausea, melanocytic nevus (moles) and ephelides (freckles), and the case reports matched these patterns. The authors call for careful patient monitoring and for safety follow-up lasting at least 1.5 years.

What it doesn’t show

The pooled rates show how often each side effect happened in people taking setmelanotide, not how much more often than without it, and they rest on only 185 people. Reports sent to a safety database flag possible signals but cannot show how common an effect is.

The paper

Sridharan and Sivaramakrishnan Adverse event profile of setmelanotide in obesity: an integrated assessment and systematic review using disproportionality analysis, case reports and meta-analysis. Expert Opin Drug Saf. 2026.

The compound

More studies on Setmelanotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo